Assessing Past Treatment History: Test-Retest Reliability of the Treatment Response to Antidepressant Questionnaire

Journal of Nervous and Mental Disease

Volumn 192, Issue 2, 2004, Pages 95-102

  Posternak, Michael A ^a,b   Young, Diane ^a   Sheeran, Thomas ^a   Chelminski, Iwona ^a   Franklin, C Laurel ^a   Zimmerman, Mark ^a  

^a BROWN UNIVERSITY   (United States)

^b Bayside Medical Center   (United States)

Author keywords

Antidepressant; History; Reliability; Test retest; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGED; ANAMNESIS; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RELIABILITY; TREATMENT OUTCOME; VALIDATION PROCESS;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS; COHORT STUDIES; DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MENTAL HEALTH SERVICES; MIDDLE AGED; OBSERVER VARIATION; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 1342325375     PISSN: 00223018     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.nmd.0000110280.19284.47     Document Type: Article

References (27)

1. Amsterdam JD, Maislin G, Potter L (1994) Fluoxetine efficacy in treatment resistant depression. Prog Neuropsychopharmacol Biol Psychiatry. 18:243-261.
2. Angst J (1961) A clinical analysis of the effects of Tofranil in depression. Psychopharmacologia. 2:381-407.
3. Bielski RJ, Friedel RO (1976) Prediction of tricyclic antidepressant response. Arch Gen Psychiatry. 33:1479-1489.
4. Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Meas. 20:37-46.
5. Endicott J, Spitzer RL (1978) A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry. 35:837-844.
6. First MB, Spitzer RL, Williams JBW, Gibbon M (1997) Structured clinical interview for DSM-IV (SCID). Washington, DC: American Psychiatric Association.
7. Fleiss JL (1991) Statistical methods for rates and proportions. New York: Wiley.
8. Grunhaus L, Remen A (1993) Assessment of treatment-resistant major depression - The Michigan Adequacy of Treatment Scale. J Clin Psychopharmacology. 13:221-223.
9. Janicak PG, Davis JM, Preskorn SH, Ayd FJ (1997) Principles and practice of psychopharmacotherapy (2nd ed). Baltimore, MD: Williams & Wilkins.
10. Joyce PR, Paykel ES (1989) Predictors of drug response in depression. Arch Gen Psychiatry. 46:89-99.
11. Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, Andreasen NC (1987) The longitudinal interval follow-up evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry. 44:540-548.
12. Keller MB, Lavori PW, McDonald-Scott P, Endicott J, Andreasen N, Eardewegh MMV (1983) The reliability of retrospective treatment reports. Psychiatry Res. 9:81-88.
13. Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RMA, Shea T (1992) Time to recovery, chronicity and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 patients. Arch Gen Psychiatry. 49:809-816.
14. Nierenberg AA, Keck PE, Samson J, Rothschild AJ, Schatzberg AF (1991) Methodological considerations for the study of treatment-resistant depression. In JD Amsterdam (Ed), Advances in neuropsychiatry and psychopharmacology (Vol 2, pp 1-12). New York: Raven Press.
15. Pare CMB, Mack JW (1971) Differentiation of two genetically specific types of depression by the response to antidepressant drugs. J Med Genet. 8:306-309.
16. Pare CMB, Rees L, Sainsbury MJ (1962) Differentiation of two genetically specific types of depression by the response to antidepressants. Lancet. 2:1340-1343.
17. Pfohl B, Blum N, Zimmerman M (1997) Structured interviewfor DSM-IV personality. Washington, DC: American Psychiatric Press.
18. Posternak MA, Zimmerman M (2003) How accurate are patients in reporting their antidepressant treatment history? J Affect Disord. 75:115-124.
19. Posternak MA, Zimmerman M (2002) Partial validation of the atypical features subtype of major depressive disorder. Arch Gen Psychiatry. 59:70-76.
20. Posternak MA, Zimmerman M, Solomon DA (2002) Integrating outcomes research into clinical practice: A pilot study. Psychiatr Serv. 53:335-336.
21. Prudic J, Haskett RF, Mulsant B, Malone KM, Pettinati JM, Stephens S, Greenberg R, Rifas SL, Sackeim HA (1996) Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry. 153:985-992.
22. Remillard AJ, Blackshaw SL, Dangor ASO (1994) Differential responses to a single antidepressant in recurrent episodes of major depression. Hosp Commun Psychiatry. 45:359-361.
23. Sackeim HA (2001) The definition and meaning of treatment-resistant depression. J Clin Psychiatry. 62(suppl 16):10-17.
24. Sackeim HA, Prudic J, Devanand DP, Decina P, Kerr B, Malitz S (1990) The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol. 10:96-104.
25. Zimmerman M, Mattia JI (1999) Psychiatric diagnosis in clinical practice: Is comorbidity being missed? Compr Psychiatry. 40:182-191.
26. Zimmerman M, Mattia JI, Posternak MA (2002) Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry. 159:469-473.
27. Zimmerman M, Posternak MA, Singer S, Attiullah N, Rahman S, Baymiller SE, Uy KK (2001) Factors influencing psychiatrists' choice of antidepressants: A prospective study. Poster presented at the American Psychiatric Association Annual Conference. New Orleans, LA.